<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName journalpublishing.dtd?>
<?SourceDTD.Version 2.3?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 2?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-id journal-id-type="hwp">bioinfo</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">3546796</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/bts681</article-id>
    <article-id pub-id-type="publisher-id">bts681</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Note</subject>
        <subj-group>
          <subject>Data and Text Mining</subject>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Bioclipse-R: integrating management and visualization of life science data with statistical analysis</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Spjuth</surname>
          <given-names>Ola</given-names>
        </name>
        <xref ref-type="aff" rid="bts681-AFF1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Georgiev</surname>
          <given-names>Valentin</given-names>
        </name>
        <xref ref-type="aff" rid="bts681-AFF1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Carlsson</surname>
          <given-names>Lars</given-names>
        </name>
        <xref ref-type="aff" rid="bts681-AFF1">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Alvarsson</surname>
          <given-names>Jonathan</given-names>
        </name>
        <xref ref-type="aff" rid="bts681-AFF1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Berg</surname>
          <given-names>Arvid</given-names>
        </name>
        <xref ref-type="aff" rid="bts681-AFF1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Willighagen</surname>
          <given-names>Egon</given-names>
        </name>
        <xref ref-type="aff" rid="bts681-AFF1">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="bts681-AFF1">
          <sup>3</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wikberg</surname>
          <given-names>Jarl E.S.</given-names>
        </name>
        <xref ref-type="aff" rid="bts681-AFF1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Eklund</surname>
          <given-names>Martin</given-names>
        </name>
        <xref ref-type="aff" rid="bts681-AFF1">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="bts681-AFF1">
          <sup>2</sup>
        </xref>
        <xref ref-type="corresp" rid="bts681-COR1">*</xref>
      </contrib>
    </contrib-group>
    <aff id="bts681-AFF1"><sup>1</sup>Department of Pharmaceutical Biosciences, Uppsala University, SE-751 24 Uppsala, Sweden, <sup>2</sup>AstraZeneca Research and Development, SE-431 83 Mölndal, Sweden and <sup>3</sup>Department of Bioinformatics - BiGCaT, Maastricht University, NL-6200 MD Maastricht, The Netherlands</aff>
    <author-notes>
      <corresp id="bts681-COR1">*To whom correspondence should be addressed.</corresp>
      <fn>
        <p>Associate Editor: Jonathan Wren</p>
      </fn>
    </author-notes>
    <pub-date pub-type="ppub">
      <day>15</day>
      <month>1</month>
      <year>2013</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>23</day>
      <month>11</month>
      <year>2012</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>23</day>
      <month>11</month>
      <year>2012</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
    <volume>29</volume>
    <issue>2</issue>
    <fpage>286</fpage>
    <lpage>289</lpage>
    <history>
      <date date-type="received">
        <day>12</day>
        <month>7</month>
        <year>2012</year>
      </date>
      <date date-type="rev-recd">
        <day>11</day>
        <month>11</month>
        <year>2012</year>
      </date>
      <date date-type="accepted">
        <day>17</day>
        <month>11</month>
        <year>2012</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author 2012. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com</copyright-statement>
      <copyright-year>2012</copyright-year>
      <license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/3.0">
        <license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <abstract>
      <p><bold>Summary:</bold> Bioclipse, a graphical workbench for the life sciences, provides functionality for managing and visualizing life science data. We introduce Bioclipse-R, which integrates Bioclipse and the statistical programming language R. The synergy between Bioclipse and R is demonstrated by the construction of a decision support system for anticancer drug screening and mutagenicity prediction, which shows how Bioclipse-R can be used to perform complex tasks from within a single software system.</p>
      <p><bold>Availability and implementation:</bold> Bioclipse-R is implemented as a set of Java plug-ins for Bioclipse based on the R-package rj. Source code and binary packages are available from <ext-link ext-link-type="uri" xlink:href="https://github.com/bioclipse">https://github.com/bioclipse</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.bioclipse.net/bioclipse-r">http://www.bioclipse.net/bioclipse-r</ext-link>, respectively.</p>
      <p>
        <bold>Contact:</bold>
        <email>martin.eklund@farmbio.uu.se</email>
      </p>
      <p><bold>Supplementary information:</bold><ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/cgi/content/full/bts681/DC1">Supplementary data</ext-link> are available at <italic>Bioinformatics</italic> online.</p>
    </abstract>
    <counts>
      <page-count count="4"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec id="SEC1">
    <title>1 INTRODUCTION</title>
    <p>Bioclipse (<xref ref-type="bibr" rid="bts681-B14">Spjuth <italic>et al.</italic>, 2007</xref>, <xref ref-type="bibr" rid="bts681-B15">2009</xref>) and R (<xref ref-type="bibr" rid="bts681-B11">R Development Core Team, 2011</xref>) are free and open source software systems for the life sciences and for statistics, respectively. Although Bioclipse has excellent functionality for managing, editing and visualizing chemical and biological information, it lacks data analytical capabilities. R, on the other hand, is outstanding for statistics and data analysis, but does not provide functionality for interactively reading, editing and visualizing chemical structures or protein sequences. In this applications note, we describe and demonstrate Bioclipse-R, a set of Bioclipse plug-ins that link Bioclipse to R and provide access to R methods from within Bioclipse.</p>
    <p>The Bioconductor project (<xref ref-type="bibr" rid="bts681-B4">Gentleman <italic>et al.</italic>, 2004</xref>) has equipped R with tailor made functionality for biology. However, Bioconductor is primarily targeted at genomics and has no functionality for chemistry. The R package rcdk adds core cheminformatics functionality to R but is not focused on providing a rich graphical user experience with functionality for editing and visualizing chemical data in 2D and 3D. Other tools for integrating R in graphical user interfaces with applications in biology and chemistry include the workflow tools Konstanz Information Miner (KNIME) (<xref ref-type="bibr" rid="bts681-B21">Warr, 2012</xref>) and Taverna (<xref ref-type="bibr" rid="bts681-B10">Oinn <italic>et al.</italic>, 2004</xref>). These provide nodes in a workflow that are capable of containing R code, but they are focused on constructing reproducible workflows and do not expose R in a workbench environment where it can be used programmatically and in combination with other tools in a more investigative fashion. In contrast to these tools, Bioclipse-R integrates R with the rich client Bioclipse and, thus, provides cross-fertilization between R and all other functionality in Bioclipse, for example, advanced visualizations, help systems and semantic data management (<xref ref-type="bibr" rid="bts681-B22">Willighagen <italic>et al.</italic>, 2011</xref>).</p>
    <p>We demonstrate the synergy between Bioclipse and R by constructing a decision support system for virtual screening and mutagenicity testing of new cancer drugs. Constructing this system without the integration between Bioclipse and R would require extensive efforts of copying data between various software tools and file formats, but is almost trivial with Bioclipse-R. Here, we outline the basic steps of the demonstration and refer to <ext-link ext-link-type="uri" xlink:href="http://bioclipse.net/bioclipse-r">http://bioclipse.net/bioclipse-r</ext-link> for a detailed step-by-step description. The operations can be performed both in the Bioclipse Scripting Language (BSL) and in Bioclipse’ graphical user interface.</p>
  </sec>
  <sec id="SEC2">
    <title>2 DEMONSTRATION</title>
    <p>This section describes the workflow for constructing the decision support system for virtual screening and mutagenicity testing of new cancer drugs. It consists of three parts: (i) construction of a quantitative structure-activity relationships (QSAR) model for anticancer activity; (ii) construction of a QSAR model for mutagenicity; and (iii) using the models constructed in (i) and (ii) to perform a virtual screen of the DrugBank approved drugs database for non-mutagenic compounds with anticancer activity.</p>
    <sec id="SEC2.1">
      <title>2.1 Cancer cell line growth inhibition modelling</title>
      <p>The NCI60 is a panel of 59 cancer cell lines developed by the National Cancer Institute (NCI), which is used for screening of new anticancer drug candidates (see, e.g. <xref ref-type="bibr" rid="bts681-B13">Shoemaker, 2006</xref>). Using a set of 3515 chemical compounds screened against the glioblastoma cell line U251, we built a QSAR model to predict whether a new compound has anticancer activity according to the following workflow:
<list list-type="order"><list-item><p><italic>Import and inspect molecules</italic>. The chemical structures were downloaded as a Simplified Molecular-Input Line-Entry System (SMILES)-formatted file and imported into a new project in Bioclipse. Bioclipse uses the Chemistry Development Kit (CDK) (<xref ref-type="bibr" rid="bts681-B18">Steinbeck <italic>et al.</italic>, 2003</xref>) as the cheminformatics library for input, output and internal representation of chemical structures, as well as for structure diagram generation and rendering. The Bioclipse Molecules Table (<xref ref-type="fig" rid="bts681-F1">Figs 1</xref>a and <xref ref-type="fig" rid="bts681-F2">2</xref>) and the chemical structure editor JChemPaint (<xref ref-type="bibr" rid="bts681-B8">Krause <italic>et al.</italic>, 2000</xref>) were used to inspect the chemical structures.</p></list-item><list-item><p><italic>Generate 3D coordinates</italic>. We used the Balloon (<xref ref-type="bibr" rid="bts681-B19">Vainio and Johnson, 2007</xref>) Bioclipse plug-in to generate 3D coordinates for the molecules so we could view the molecules in the integrated 3D viewer Jmol (<xref ref-type="bibr" rid="bts681-B6">Hanson, 2010</xref>) and compute descriptors that require 3D coordinates.</p></list-item><list-item><p><italic>Compute descriptors for the molecules</italic>. Constitutional, electronic, atomic, molecular and topological descriptors were computed with the Bioclipse-QSAR plug-in (<xref ref-type="bibr" rid="bts681-B16">Spjuth <italic>et al.</italic>, 2010</xref>), which can be used both form a graphical user interface and through a scripting interface (<xref ref-type="fig" rid="bts681-F1">Fig. 1</xref>). The descriptors were calculated for compounds in their neutral state.</p></list-item><list-item><p><italic>Build and validate QSAR model</italic>. Using R from within Bioclipse, we split the U251 dataset into a training set containing 2515 molecules and a test set containing 1000 molecules (the split was done by random selection). Using the training data, we built a random forest model to discriminate between compounds with and without anticancer activity [the R-package ‘randomForest’ (<xref ref-type="bibr" rid="bts681-B9">Liaw and Wiener, 2002</xref>) with the default parameter settings was used]. We then used the model to predict the activity of the compounds in the test set, resulting in an area under the receiver operating characteristics curve (AUC) of 77.8% (95% confidence interval: 74.9–80.7%), indicating relatively good predictive performance [the R-package ‘pROC’ (<xref ref-type="bibr" rid="bts681-B12">Robin <italic>et al.</italic>, 2011</xref>) was used for computing the AUC]. For details and R-code, see <ext-link ext-link-type="uri" xlink:href="http://pele.farmbio.uu.se/bcr/bcr-screening.html">http://pele.farmbio.uu.se/bcr/bcr-screening.html</ext-link>.</p></list-item></list>
<fig id="bts681-F1" position="float"><label>Fig. 1.</label><caption><p>(<bold>a</bold>) Dataset creation by calculating descriptors using the graphical components in Bioclipse. (<bold>b</bold>) The same dataset calculation using a script in the Bioclipse Scripting Language. This is a part of the demonstration example <italic>Mutagenicity modelling</italic>; the full tutorial is available in the <ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/CBIO/bts681/-/DC1">Supplementary Material</ext-link></p></caption><graphic xlink:href="bts681f1p"/></fig>
<fig id="bts681-F2" position="float"><label>Fig. 2.</label><caption><p>Screenshot of Bioclipse with the R-script for building the predictive model in the <italic>Mutagenicity modelling</italic> with the ROC curve shown in the plot. The full tutorial is available in the <ext-link ext-link-type="uri" xlink:href="http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/CBIO/bts681/-/DC1">Supplementary Material</ext-link> at <ext-link ext-link-type="uri" xlink:href="http://bioclipse.net/bioclipse-r">http://bioclipse.net/bioclipse-r</ext-link></p></caption><graphic xlink:href="bts681f2p"/></fig></p>
    </sec>
    <sec id="SEC2.2">
      <title>2.2 Mutagenicity modelling</title>
      <p>As it is not uncommon for anticancer drugs to be mutagenic, we wanted to be able to test compounds predicted to have anticancer activity for mutagenicity. We, therefore, constructed a QSAR model predicting mutagenicity based on a set of 6504 compounds tested with the Ames assay (<xref ref-type="bibr" rid="bts681-B5">Hansen <italic>et al.</italic>, 2009</xref>). This was done as follows:
<list list-type="order"><list-item><p><italic>Import and inspect molecules</italic>. (Analogous to 1).</p></list-item><list-item><p><italic>Compute signature descriptors and set</italic><italic>-</italic><italic>up dataset</italic>. Signature descriptors (<xref ref-type="bibr" rid="bts681-B3">Faulon <italic>et al.</italic>, 2003</xref>) are of a different nature than molecular descriptors calculated with Bioclipse-QSAR in 3. The signature descriptors are provided by the Bioclipse-Decision Support (DS) plug-in (<xref ref-type="bibr" rid="bts681-B17">Spjuth <italic>et al.</italic>, 2011</xref>), instead, and because they do not require 3D coordinates, the analogue of 2 is skipped.</p></list-item><list-item><p><italic>Build and validate QSAR model</italic>. We used R within Bioclipse to split the Ames dataset into a training set and a test set, containing 5504 and 1000 molecules, respectively (by random selection). We then used the R-package ‘e1071’ (<xref ref-type="bibr" rid="bts681-B2">Dimitriadou <italic>et al.</italic>, 2010</xref>) to fit a support vector machine with a Gaussian kernel to the training set to discriminate mutagenic from non-mutagenic compounds. The parameters <inline-formula><inline-graphic xlink:href="bts681i1.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="bts681i2.jpg"/></inline-formula> in the Gaussian kernel function were optimized using a grid search, where <inline-formula><inline-graphic xlink:href="bts681i3.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="bts681i4.jpg"/></inline-formula>. Three-fold cross-validated classification error was used as objective function in the grid search. Using the support vector machine model optimized on the training data to predict the mutagenicity in the test set, we achieved an AUC of 87.85% (95% confidence interval 85.72–89.98%), indicating good predictive performance. For details and R-code, see <ext-link ext-link-type="uri" xlink:href="http://pele.farmbio.uu.se/bcr/bcr-mutagenicity.html">http://pele.farmbio.uu.se/bcr/bcr-mutagenicity.html</ext-link>.</p></list-item></list>
</p>
    </sec>
    <sec id="SEC2.3">
      <title>2.3 Virtual screening and mutagenicy prediction</title>
      <p>Using the two QSAR models for growth inhibition and mutagenicity prediction constructed in Sections 2.1 and 2.2, we screened the subset of DrugBank (<xref ref-type="bibr" rid="bts681-B7">Knox <italic>et al.</italic>, 2011</xref>) with approved drugs:
<list list-type="order"><list-item><p><italic>Screen approved compounds from DrugBank</italic>. Using the BSL and the Bioclipse-DS, JChemPaint and Jmol Bioclipse plug-ins, we iterated over the molecules in the DrugBank approved dataset, generated 3D coordinates for the compounds, computed descriptors, and predicted each molecule’s anticancer activity (using the QSAR model constructed in Section 2.1) and mutagenicity (using the QSAR model constructed in Section 2.2). Using a BSL script, we generated a table sorted on growth inhibition (<xref ref-type="fig" rid="bts681-F2">Fig. 2</xref>).</p></list-item><list-item><p><italic>Display screening hit in 2D and 3D</italic>. We inspected the top screening hits in 2D using the Bioclipse Molecules Table, which also permits easy access to DrugBank information for these compounds using hyperlinks embedded in the table that open in the internal browser in Bioclipse. Using the Balloon conformer generation, we could generate 3D coordinates and inspect the screening hits in 3D using the Jmol component in Bioclipse. The focus of this article is the integration of Bioclipse and R, and not the results of the screening <italic>per se</italic>. However, we may note that three of the top five hits from the screening model are drugs used in cancer treatment (plicamycin, oxaliplatin and daunorubicin, see <xref ref-type="fig" rid="bts681-F2">Figure 2</xref> and <ext-link ext-link-type="uri" xlink:href="http://pele.farmbio.uu.se/bcr/bcr-vscreen.html">http://pele.farmbio.uu.se/bcr/bcr-vscreen.html</ext-link>), tentatively indicating that the growth inhibition screening model does a decent job in ranking molecules.</p></list-item><list-item><p><italic>Interpret predictions</italic>. To interpret the results, we re-ran the predictions in Bioclipse Decision Support. When using the growth inhibition and mutagenicity models in Bioclipse Decision Support, the substructure that contributed the most to the prediction of a given compound’s bioactivity is highlighted. The highlighted substructure is, thus, the site where structural modification would affect the predicted bioactivity the most (<xref ref-type="fig" rid="bts681-F3">Fig. 3</xref>a). This interpretation of non-linear models is based on the method by <xref ref-type="bibr" rid="bts681-B1">Carlsson <italic>et al.</italic> (2009)</xref> and allows for guidance when exploring different hypotheses of how structural changes of molecules would affect their predictions (a screencast demonstrating this functionality in further detail is available at <ext-link ext-link-type="uri" xlink:href="http://pele.farmbio.uu.se/bcr/bcr-vscreen.html">http://pele.farmbio.uu.se/bcr/bcr-vscreen.html</ext-link>).</p></list-item></list>
<fig id="bts681-F3" position="float"><label>Fig. 3.</label><caption><p>(<bold>a</bold>) Screenshot of Bioclipse showing the chemical structure of carbamazepine, which was predicted to inhibit cancer cell growth and to be mutagenic. The circles highlight the parts of the chemical structure predicted to cause the mutagenicity (see <xref ref-type="bibr" rid="bts681-B17">Spjuth <italic>et al.</italic>, 2011</xref>). (<bold>b</bold>) Architecture of the Bioclipse-R integration. Bioclipse makes use of the StatET plug-ins for interacting with R using the R-package rj (<xref ref-type="bibr" rid="bts681-B20">Wahlbrink and Verbeke, 2011</xref>), and it makes R available both via the user interface as well as the BSL</p></caption><graphic xlink:href="bts681f3p"/></fig></p>
    </sec>
  </sec>
  <sec id="SEC3">
    <title>3 IMPLEMENTATION AND AVAILABILITY</title>
    <p>A set of plug-ins for Bioclipse were implemented in Java, adding a bridge to R. The plug-ins build on the StatET project (<ext-link ext-link-type="uri" xlink:href="http://www.walware.de/goto/statet">http://www.walware.de/goto/statet</ext-link>), which in turn uses the R-package rj (<xref ref-type="bibr" rid="bts681-B20">Wahlbrink and Verbeke, 2011</xref>) (see <xref ref-type="fig" rid="bts681-F3">Fig. 3</xref>b). Bioclipse maintains a persistent connection with R, and allows for executing commands and scripts and retrieving result back into Bioclipse, with functionality exposed both in the graphical user interface as well as from BSL.</p>
    <p>Bioclipse-R is available for the operating systems Windows, Linux and Mac OS X. Source code and binary packages are available under the Eclipse Public License (<ext-link ext-link-type="uri" xlink:href="http://www.eclipse.org/org/documents/epl-v10.php">http://www.eclipse.org/org/documents/epl-v10.php</ext-link>) from <ext-link ext-link-type="uri" xlink:href="https://github.com/bioclipse">https://github.com/bioclipse</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.bioclipse.net/bioclipse-r">http://www.bioclipse.net/bioclipse-r</ext-link>, respectively.</p>
  </sec>
  <sec id="SEC4">
    <title>4 CONCLUSION</title>
    <p>We show how we can conduct advanced tasks from within a single software platform by leveraging the functionality in Bioclipse and R. The demonstration shows the cross-fertilization between R and numerous Bioclipse components (CDK, Balloon, Bioclipse-QSAR, Bioclipse-DS, JChemPaint and Jmol). It also shows how Bioclipse-R allows for easy access to statistical models fitted in R from a graphical user interface as well as from BSL scripts, thus allowing for automation and exchange of complete Bioclipse-R workflows. Bioclipse-R also enriches the bioinformatics functionality in Bioclipse through access to Bioconductor via R. The plug-in-based architecture of Bioclipse makes extensions simple, and future development of Bioclipse-R will include a user-friendly graphical interface for performing statistical analyses.</p>
    <p><italic>Funding:</italic> Support from <funding-source>Uppsala University (KoF 07)</funding-source>, <funding-source>Swedish VR-2011-6129</funding-source>, and the Swedish strategic research program eSSENCE.</p>
    <p><italic>Conflict of Interest:</italic> none declared.</p>
  </sec>
</body>
<back>
  <ref-list>
    <title>REFERENCES</title>
    <ref id="bts681-B1">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Carlsson</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Interpretation of nonlinear QSAR models applied to Ames mutagenicity data</article-title>
        <source>J. Chem. Inf. Model.</source>
        <year>2009</year>
        <volume>49</volume>
        <fpage>2551</fpage>
        <lpage>2558</lpage>
        <pub-id pub-id-type="pmid">19824682</pub-id>
      </element-citation>
    </ref>
    <ref id="bts681-B2">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dimitriadou</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>e1071: Misc functions of the Department of Statistics (e1071)</article-title>
        <year>2010</year>
        <comment>TU Wien. R package version 1.5-24</comment>
      </element-citation>
    </ref>
    <ref id="bts681-B3">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Faulon</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The signature molecular descriptor: part 1. Using extended valence sequences in QSAR and QSPR studies</article-title>
        <source>J. Chem. Inf. Comput. Sci.</source>
        <year>2003</year>
        <volume>43</volume>
        <fpage>707</fpage>
        <lpage>720</lpage>
        <pub-id pub-id-type="pmid">12767129</pub-id>
      </element-citation>
    </ref>
    <ref id="bts681-B4">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gentleman</surname>
            <given-names>RC</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Bioconductor: open software development for computational biology and bioinformatics</article-title>
        <source>Genome Biol.</source>
        <year>2004</year>
        <volume>5</volume>
        <fpage>R80</fpage>
        <pub-id pub-id-type="pmid">15461798</pub-id>
      </element-citation>
    </ref>
    <ref id="bts681-B5">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hansen</surname>
            <given-names>K</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Benchmark data set for in silico prediction of Ames mutagenicity</article-title>
        <source>J. Chem. Inf. Model.</source>
        <year>2009</year>
        <volume>49</volume>
        <fpage>2077</fpage>
        <lpage>2081</lpage>
        <pub-id pub-id-type="pmid">19702240</pub-id>
      </element-citation>
    </ref>
    <ref id="bts681-B6">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hanson</surname>
            <given-names>RM</given-names>
          </name>
        </person-group>
        <article-title>Jmol—a paradigm shift in crystallographic visualization</article-title>
        <source>J. Appl. Crystallogr.</source>
        <year>2010</year>
        <volume>43</volume>
        <issue>5 Part 2</issue>
        <fpage>1250</fpage>
        <lpage>1260</lpage>
      </element-citation>
    </ref>
    <ref id="bts681-B7">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Knox</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>DrugBank 3.0: a comprehensive resource for ‘omics’ research on drugs</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2011</year>
        <volume>39</volume>
        <fpage>D1035</fpage>
        <lpage>D1041</lpage>
        <pub-id pub-id-type="pmid">21059682</pub-id>
      </element-citation>
    </ref>
    <ref id="bts681-B8">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Krause</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>JChemPaint—using the collaborative forces of the internet to develop a free editor for 2D chemical structures</article-title>
        <source>Molecules</source>
        <year>2000</year>
        <volume>5</volume>
        <fpage>93</fpage>
        <lpage>98</lpage>
      </element-citation>
    </ref>
    <ref id="bts681-B9">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liaw</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Wiener</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Classification and regression by randomForest</article-title>
        <source>R News</source>
        <year>2002</year>
        <volume>2</volume>
        <fpage>18</fpage>
        <lpage>22</lpage>
      </element-citation>
    </ref>
    <ref id="bts681-B10">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Oinn</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Taverna: a tool for the composition and enactment of bioinformatics workflows</article-title>
        <source>Bioinformatics</source>
        <year>2004</year>
        <volume>20</volume>
        <fpage>3045</fpage>
        <lpage>3054</lpage>
        <pub-id pub-id-type="pmid">15201187</pub-id>
      </element-citation>
    </ref>
    <ref id="bts681-B11">
      <element-citation publication-type="book">
        <collab>R Development Core Team</collab>
        <source>R: A Language and Environment for Statistical Computing</source>
        <year>2011</year>
        <publisher-loc>Vienna, Austria</publisher-loc>
        <publisher-name>R Foundation for Statistical Computing</publisher-name>
        <comment>ISBN 3-900051-07-0</comment>
      </element-citation>
    </ref>
    <ref id="bts681-B12">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Robin</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>pROC: an open-source package for R and S+ to analyze and compare ROC curves</article-title>
        <source>BMC Bioinformatics</source>
        <year>2011</year>
        <volume>12</volume>
        <fpage>77</fpage>
        <pub-id pub-id-type="pmid">21414208</pub-id>
      </element-citation>
    </ref>
    <ref id="bts681-B13">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shoemaker</surname>
            <given-names>RH</given-names>
          </name>
        </person-group>
        <article-title>The NCI60 human tumour cell line anticancer drug screen</article-title>
        <source>Nat. Rev. Cancer</source>
        <year>2006</year>
        <volume>6</volume>
        <fpage>813</fpage>
        <lpage>823</lpage>
        <pub-id pub-id-type="pmid">16990858</pub-id>
      </element-citation>
    </ref>
    <ref id="bts681-B14">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Spjuth</surname>
            <given-names>O</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Bioclipse: an open source workbench for chemo- and bioinformatics</article-title>
        <source>BMC Bioinformatics</source>
        <year>2007</year>
        <volume>8</volume>
        <fpage>59</fpage>
        <pub-id pub-id-type="pmid">17316423</pub-id>
      </element-citation>
    </ref>
    <ref id="bts681-B15">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Spjuth</surname>
            <given-names>O</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Bioclipse 2: a scriptable integration platform for the life sciences</article-title>
        <source>BMC Bioinformatics</source>
        <year>2009</year>
        <volume>10</volume>
        <fpage>397</fpage>
        <pub-id pub-id-type="pmid">19958528</pub-id>
      </element-citation>
    </ref>
    <ref id="bts681-B16">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Spjuth</surname>
            <given-names>O</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Towards interoperable and reproducible QSAR analyses: exchange of datasets</article-title>
        <source>J. Cheminform.</source>
        <year>2010</year>
        <volume>2</volume>
        <fpage>5</fpage>
        <pub-id pub-id-type="pmid">20591161</pub-id>
      </element-citation>
    </ref>
    <ref id="bts681-B17">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Spjuth</surname>
            <given-names>O</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Integrated decision support for assessing chemical liabilities</article-title>
        <source>J. Chem. Inf. Model.</source>
        <year>2011</year>
        <volume>51</volume>
        <fpage>1840</fpage>
        <lpage>1847</lpage>
        <pub-id pub-id-type="pmid">21774475</pub-id>
      </element-citation>
    </ref>
    <ref id="bts681-B18">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Steinbeck</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Chemistry Development Kit (CDK): an open-source java library for chemo- and bioinformatics</article-title>
        <source>J. Chem. Inf. Comput. Sci.</source>
        <year>2003</year>
        <volume>43</volume>
        <fpage>493</fpage>
        <lpage>500</lpage>
        <pub-id pub-id-type="pmid">12653513</pub-id>
      </element-citation>
    </ref>
    <ref id="bts681-B19">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vainio</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>MS</given-names>
          </name>
        </person-group>
        <article-title>Generating conformer ensembles using a multiobjective genetic algorithm</article-title>
        <source>J. Chem. Inf. Model</source>
        <year>2007</year>
        <volume>47</volume>
        <fpage>2462</fpage>
        <lpage>2474</lpage>
        <pub-id pub-id-type="pmid">17892278</pub-id>
      </element-citation>
    </ref>
    <ref id="bts681-B20">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wahlbrink</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Verbeke</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>RJ: R Package for high-level Java-R library RJ</article-title>
        <year>2011</year>
        <comment>R package version 0.5.5-2</comment>
      </element-citation>
    </ref>
    <ref id="bts681-B21">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Warr</surname>
            <given-names>WA</given-names>
          </name>
        </person-group>
        <article-title>Scientific workflow systems: pipeline pilot and KNIME</article-title>
        <source>J. Comput. Aided Mol. Des.</source>
        <year>2012</year>
        <volume>26</volume>
        <fpage>801</fpage>
        <lpage>804</lpage>
        <pub-id pub-id-type="pmid">22644661</pub-id>
      </element-citation>
    </ref>
    <ref id="bts681-B22">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Willighagen</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Linking the resource description framework to cheminformatics and proteochemometrics</article-title>
        <source>J. Biomed. Semantics</source>
        <year>2011</year>
        <volume>2</volume>
        <issue>Suppl. 1</issue>
        <fpage>S6</fpage>
        <pub-id pub-id-type="pmid">21388575</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
